Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-04-18 3:56 pm Purchase |
2022-04-18 | 13G | OncoCyte Corporation OCX |
Halle Special Situations Fund LLC | 356,473 6.000% |
356,473 (New Position) |
Filing History |
| 2022-04-15 5:21 pm Purchase |
2022-04-13 | 13D | OncoCyte Corporation OCX |
BROADWOOD PARTNERS LP | 1,188,748 19.990% |
296,969 (+33.30%) |
Filing History |
| 2022-02-04 4:12 pm Purchase |
2021-12-31 | 13G | OncoCyte Corporation OCX |
BLACKROCK INC BLK |
249,657 5.400% |
69,906 (+38.89%) |
Filing History |
| 2021-09-24 4:40 pm Unchanged |
2021-09-23 | 13D | OncoCyte Corporation OCX |
BROADWOOD PARTNERS LP | 891,780 19.300% |
0 (Unchanged) |
Filing History |
| 2021-02-10 3:04 pm Purchase |
2021-01-31 | 13G | OncoCyte Corporation OCX |
BLACKROCK INC BLK |
179,752 4.600% |
4,650 (+2.66%) |
Filing History |
| 2021-02-09 5:10 pm Purchase |
2021-02-05 | 13D | OncoCyte Corporation OCX |
BROADWOOD PARTNERS LP | 891,780 20.100% |
30,000 (+3.48%) |
Filing History |
| 2021-02-02 3:13 pm Purchase |
2020-12-31 | 13G | OncoCyte Corporation OCX |
BLACKROCK INC BLK |
175,102 5.200% |
175,102 (New Position) |
Filing History |
| 2021-01-28 3:44 pm Purchase |
2021-01-20 | 13G | OncoCyte Corporation OCX |
Pura Vida Investments, LLC | 611,198 15.540% |
326,369 (+114.58%) |
Filing History |
| 2021-01-22 4:18 pm Purchase |
2021-01-20 | 13D | OncoCyte Corporation OCX |
BROADWOOD PARTNERS LP | 861,780 21.600% |
253,911 (+41.77%) |
Filing History |
| 2021-01-08 5:00 pm Sale |
2021-01-07 | 13D | ASTERIAS BIOTHERAPEUTICS, INC. AST |
Lineage Cell Therapeutics Inc. LCTX |
3,297,401 4.900% |
-968,503 (-22.70%) |
Filing History |
| 2020-04-27 5:28 pm Sale |
2020-04-23 | 13D | ASTERIAS BIOTHERAPEUTICS, INC. AST |
Lineage Cell Therapeutics Inc. LCTX |
4,265,904 6.300% |
-1,775,250 (-29.39%) |
Filing History |